Beschreibung: | genes as patentable subject-matter - discovery or invention? - Federal German Patent Court - Artamanide-case - the Biopatent Directive 98/44/EC - patent scope for gene patents - the Monsanto decision of the ECJ C-428/08
"Patenting of genes remains one of the most controversial topics of biotechnological patent law. At first, it is questionable whether genes should be treated as patentable inventions at all. The isolation requirement displaces the clear line between patentable subject-matter and discoveries and therefore transfers patent protection in the field of “public domain”. This problem is increased by the fact that DNA sequences are not only chemical compounds, but also carriers of genetic information. On the other hand, patenting DNA sequences has the function of securing investments in biotechnology industry. A moderate limitation of the patent scope therefore appears as an adequate solution, because it reflects the inventor’s performance of indicating the function of gene and also avoids an “over-rewarding” of the inventor and a too broad patent scope. The recent “Monsanto”-decision of the ECJ therefore points in the right direction." (J. Timke) |